June 20 (Reuters) - Becton Dickinson and Co BDX.N :
* BD TO SELL SURGICAL INSTRUMENTATION PLATFORM TO STERIS
* BD - OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED
* BD: TO SELL ITS SURGICAL INSTRUMENTATION PLATFORM TO
STERIS FOR
$540 MILLION
* BD - IF DEAL CLOSES AS EXPECTED WITHIN BD'S FISCAL YEAR
2023,
IMPACT TO ADJUSTED EARNINGS PER SHARE (EPS) WOULD BE IMMATERIAL
* BD - DIVESTITURE WILL INCLUDE V. MUELLER, SNOWDEN-PENCER
AND
GENESIS BRANDED PRODUCTS
* BD: CASH PROCEEDS FROM DEAL WILL BE DEPLOYED CONSISTENT
WITH
BD'S CAPITAL ALLOCATION PRIORITIES
* BD - DIVESTITURE WILL ALSO INCLUDE THREE MANUFACTURING
FACILITIES LOCATED IN ST. LOUIS, MO., CLEVELAND, OHIO AND
TUTTLINGEN, GERMANY
* BD - ABOUT 360 EMPLOYEES WHO SUPPORT SURGICAL
INSTRUMENTATION
PLATFORM WILL TRANSFER TO STERIS UPON COMPLETION OF DEAL
Source text for Eikon: ID:nPn2MGkBva
Further company coverage: BDX.N
(Reuters.Briefs@thomsonreuters.com)